AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (1.8 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Publishing Language: Chinese

Interleukin-6 and Irritable Bowel Syndrome: Mechanisms and Research Advances

Li LIU1, Chunhua ZHAO2( ), Han MIN1,2( )
Department of Gastroenterology, The Affiliated Suzhou Hospital of Nanjing Medical University (Suzhou Municipal Hospital, Suzhou Women and Children's Heath Hospital), Suzhou, Jiangsu 215001, China
Medical Big Data Center, The Affiliated Suzhou Hospital of Nanjing Medical University (Suzhou Municipal Hospital, Suzhou Women and Children's Heath Hospital), Suzhou, Jiangsu 215001, China
Show Author Information

Abstract

Irritable bowel syndrome (IBS) is an extremely common chronic intestinal disorder characterized by recurrent abdominal pain and altered bowel habits, significantly impacting patients' quality of life. The etiology of IBS remains incompletely understood. Research has identified low-grade intestinal inflammation and immune activation, primarily manifested as an imbalance between pro-inflammatory and anti-inflammatory cytokines, as key pathogenic mechanisms in IBS. Among these, interleukin-6 (IL-6), a core pro-inflammatory cytokine, is significantly elevated in IBS patients. IL-6 contributes to the pathogenesis of IBS through various mechanisms, including altering individual susceptibility to IBS, promoting gastrointestinal motility and secretion, activating the hypothalamic-pituitary-adrenal axis, inducing visceral hypersensitivity, and impairing intestinal mucosal barrier function. Furthermore, IL-6 levels are closely associated with the severity of IBS symptoms. This review summarizes the role and mechanisms of IL-6 in IBS, aiming to provide insights and references for clinicians and researchers investigating the etiology of IBS.

CLC number: R574; R363.1 Document code: A Article ID: 1674-9081(2025)02-0431-08

References

【1】
【1】
 
 
Medical Journal of Peking Union Medical College Hospital
Pages 431-438

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
LIU L, ZHAO C, MIN H. Interleukin-6 and Irritable Bowel Syndrome: Mechanisms and Research Advances. Medical Journal of Peking Union Medical College Hospital, 2025, 16(2): 431-438. https://doi.org/10.12290/xhyxzz.2024-0491

1970

Views

40

Downloads

0

Crossref

1

Scopus

0

CSCD

Received: 02 July 2024
Accepted: 05 August 2024
Published: 03 March 2025
© 2025 Medical Journal of Peking Union Medical College Hospital